Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pediatric Crohn's disease × Methotrexate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Leukemia 37 Breast Neoplasms 26 Lymphoma 18 Leukemia, Myeloid, Acute 14 Burkitt Lymphoma 12 Myelodysplastic Syndromes 10 Graft vs Host Disease 9 Squamous Cell Carcinoma of Head and Neck 6 Urinary Bladder Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Osteosarcoma 4 Leukemia, Promyelocytic, Acute 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Biphenotypic, Acute 4 Hodgkin Disease 4 Head and Neck Neoplasms 4 Arthritis, Rheumatoid 4 Anemia, Refractory, with Excess of Blasts 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Dendritic Cell Sarcoma, Interdigitating 3 Urethral Neoplasms 2 Sarcoma 2 Rhabdoid Tumor 2

Interventions

Sugars 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02772965 2023-04-12

COMBINE

University of North Carolina, Chapel Hill

Phase 3 Completed

306 enrolled 16 charts

Pediatric Crohn's disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡